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ABSTRACT
￿
Fibronectin and certain polypeptide regions of this adhesive glycoprotein mediate
cell attachment and spreading on various substrates. We explored the theoretical prediction
that this adhesive protein could become a competitive inhibitor of fibronectin-mediated
processes if present in solution at appropriately high concentrations. Fibronectin function was
inhibited by purified plasma fibronectin at 5-10 mg/ml, by a 75,000-dalton cell-interaction
fragment of the protein at 0.5-1 mg/ml, and even by two synthetic peptides containing a
conserved, hydrophilic amino acid sequence at 0.1-0.5 mg/ml. Inhibition of fibronectin-
dependent cell spreading was dose dependent, noncytotoxic, and reversible . It was compet-
itive in nature, since increased quantities of substrate-adsorbed fibronectin or longer incuba-
tion periods decreased the inhibition. A peptide inhibitory for fibronectin-mediated cell
spreading also inhibited fibronectin-mediated attachment of cells to type I Collagen, but it did
not affect concanavalin A-mediated spreading.
These results demonstrate the potential of a cell adhesion molecule and its biologically
active peptide fragments to act as competitive inhibitors, and they suggest that fibronectin
may act by binding to a saturable cell surface receptor.
Cell adhesion to other cells or to substrates is a complex
process which is still poorly understoodat the molecular level
(e.g., references 1 and 2). Adhesive events mediated by fibro-
nectin and other extracellular attachment proteins provide
experimental systems for analyzing polypeptide domains that
mediate binding and adhesive functions (3-9). For example,
a region offibronectintermed the "cell-binding" region, which
interacts with the cell surface to mediate cell attachment and
spreading on substrates, has been identified and localized to
polypeptide fragments (10, 11). Even a synthetic peptide from
this region of fibronectin can mediate cell attachment to a
plastic substrate (12).
Theoretically, a cell adhesion protein might become a spe-
cific inhibitor of its own function if it were bound in excess
to a cellular receptor. Saturation of receptors by soluble
adhesive molecules might prevent receptor interactions with
substrate- or cell-attached adhesive molecules. A rough anal-
ogy might be the prozone effect in immunoprecipitation, in
which an excess ofantibody can saturate siteson antigens and
prevent the formation ofaggregates.
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We tested this theoretical model with soluble plasma fibro-
nectin and certain peptide fragments of this glycoprotein.
These molecules were found to be competitive, reversible
inhibitors of fibronectin function. Our results suggest that
adhesive proteins can have a dualistic nature, mediating pos-
itive or negative effects depending on their concentrations
and whether they are in solution or attached to a substrate.
MATERIALS AND METHODS
Fibronectin and Fibronectin Fragments:
￿
Plasma fibronectinwas
isolated from human plasma (National Institutes ofHealth Blood Bank), either
by sequentialgelatin-Sepharoseandheparin-Sepharoseaffinitychromatography
with elution andwashing by 4Murea as described(l3, 14) or by elution under
nondenaturingconditionsat pH 5.5 from agelatin-Sepharosecolumn(15), and
centrifuged at 25,000 gfor 15 min; results with either type ofpreparation were
similar. As shown previously (11), such fibronectin preparations migrated as a
homogeneous doublet band in SDSpolyacrylamide gels.
The75,000-dalton cell-binding fiagment wasgenerated by tryptic digestion
of human plasma fibronectin and purified exactly as described previously(11).
A 60,000-dalton collagen-binding fragment was generated by digestion of
human plasmafibronectinby 5,ug/ml «-chymotrypsin(Worthington Biochem-
29FIGURE 1
￿
Autoinhibition of fibronectin-mediated cell spreading . (a) Control BHK cells spreading on a tissue culture dish precoated
with 3 Fig/ml plasma fibronectin, followed by BSA to block nonspecific interactions, as described in Materials and Methods . (b)
BHK cells on a parallel, fibronectin-coated dish in the presence of 10 mg/ml soluble plasma fibronectin (FN) . (c) BHK cells on a
fibronectin-coated dish in the presence of 1 .0 mg/ml 75,000-dalton cell-binding fragment (75K) of fibronectin . Phase-contrast
microscopy; bar, 50 ,um .
ical Corp ., Freehold, NJ ; 50 U/mg) in 150 mM NaCl, I mM CaC12, and 10
mM Tris-HCI, pH 7 .4, for 30 min at room temperature . The reaction was
terminated with soybean trypsin inhibitor (Sigma Chemical Co., St. Louis,
MO)at 10Ag/ml, and the 60,000-dalton collagen-binding fragment was purified
by sequential gelatin-Sepharose and Sephacryl S-200 chromatography essen-
tially as described for a similar fragment from chicken cellular fibronectin,
except that the fragment was eluted from the gelatin affinity column with 4 M
rather than 8 M urea, and the gel permeation column waseluted with 150mM
NaCl, 10 mM Tris-HCI, pH 7.4 (16). The synthetic peptides Arg-Gly-Asp-Ser-
Pro-Ala-Ser-Ser-Lys-Pro (peptide I), Gly-Arg-Gly-Asp-Ser-Pro-Cys (peptide II),
and Cys-Gln-Asp-Ser-Glu-Thr-Arg-Thr-Phe-Tyr (peptide III) were purchased
from Peninsula Laboratories, Inc ., Belmont, CA . They werepurified further by
chromatography on TSK HW-40(S) Fractogel columns (2 .5 x 100 cm, flow
rate 12-15 ml/h ; Pierce Chemical Co., Rockford, IL), and their compositions
were confirmed by quantitative amino acid analyses .
Peptide Il was alkylated where indicated as follows: 20 pmol of cell-binding
peptide II was incubated with 40 mM dithiothreitol (Calbiochem-Behring
Corp ., San Diego, CA) in 0 .5 M Tris-HCI, 2 mM EDTA, pH 8 .5, under a
nitrogen atmosphere for 4 h at 37°C. The samples were alkylated by incubation
with 0.1 M iodoacetic acid (Aldrich Chemical Co., Milwaukee, WI) for 30 min
at room temperature in the dark. The reaction was terminated by the addition
ofexcess dithiothreitol (final concentration 0.13 M). The alkylated peptide was
isolated by rechromatography on a TSK HW-40(S) (Pierce Chemical Co .)
column .
Biological Assays :
￿
Quantitation of fibronectin-mediated cell spread-
ing ofBHK (baby hamster kidney)' cells and CHO (Chinese hamster ovary)
cell attachment to type I collagen was performed as described (16, 17) . Based
on quantitative fibronectin adsorption data published by Grinnell and Feld
(18), the cell-spreadingassay was modified as follows to prevent further adsorp-
tion of soluble fibronectin to the substrate during assays: 16-mm multiwell or
35-mm tissue culture dishes (Costar, Data Packaging, Cambridge, MA) were
preincubated with 3 ug/ml plasma fibronectin in 0 .3 or 1 .0 ml adhesion
medium, respectively, for 60 min at room temperature (23-24°C) . All remain-
ing proteinadsorption sites were saturatedwith 10 mg/mI heat-denatured (80°C
for 3 min) BSA for 30 min . Cells were incubated in adhesion medium (150
mM NaCl, 3 mM KCI, I mM CaC12, 0 .5 mM M9C12 , 6mM Na2HPO4 , 1 MM
KH 2PO4 , pH 7 .3; reference 17) with or without added soluble fibronectin or its
fragments for 45 min at 37°C. After this attachment period, cells were fixed
with 2.5% glutaraldehyde in Dulbecco's PBS for >I h, and cell spreading was
quantitated as described (16, 17).
Controls for the possible nonspecific effects of protein present during the
cell-spreading assay included incubation with 10 mg/ml BSA, fibrinogen, or
ovalbumin from Calbiochem-Behring, as well as fetuin (types III and IV),
transferrin, soybean trypsin inhibitor, cytochrome c, hemoglobin, and myoglo-
bin from Sigma Chemical Co .
'Abbreviations used in this paper: BHK, baby hamster kidney ;
CHO, Chinese hamster ovary.
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Additional peptide controls were : fibrinopeptide A and luteinizing hormone
purchased from Vega Biochemicals, Tucson, AZ ; tuftsin obtained from Calbi-
ochem-Behring ; and adrenocorticotropin, angiotensin I, aprotinin, bradykinin,
fibrinopeptide B, a-melanocyte-stimulating hormone, neurotensin, oxytocin,
Arg-Gly-Pro-Phe-Pro-lle, Gly-Pro-Arg-Pro, Arg-Asp, Gly-Asp, and mixtures of
free amino acids corresponding to synthetic peptide I and synthetic peptide II,
all purchased from Sigma. The pH of samples was adjusted to pH 7 with HCI
or NaOH .
Reversibility and Amino Acid Incorporation Experiments:
BHK cells were incubated for 45 min in the standard cell-spreading assay on
substrates coated with 3 irg/ml plasma fibronectin with or without added 10
mg/ml human plasmafibronectin or0.5 mg/ml peptide I or peptide 11 . Cultures
were fixed with glutaraldehyde to determine the extent of spreading at 45 min,
and parallel cultures were gently washed three times with adhesion medium
lacking inhibitors and incubated further for 45 min at 37°C . Other parallel
cultures were incubated for the additional 45 min with the inhibitors .
Amino acid incorporation was determined for BHK cells incubated in the
standard spreadingassay in Costar 35-mm dishes containing adhesion medium
with 1 mM glucose and 1 kCi/ml "C-amino acids mixture (Amersham Corp .) .
After 45 min at 37°C, the cultures were rinsed with Dulbecco's PBS, solubilized
with 1 N NaOH, and neutralized with HCI . After precipitation with 10%
trichloroacetic acid at 4°C, collection, and washing on Millipore (Bedford, MA)
HAWP filters, radioactivity was determined in a scintillation spectrometer.
nectin-mediated Cell Spreading :
￿
Freshly prepared solutions of
concanavalin A (Pharmacia Inc ., Uppsala, Sweden) were preincubatedwith 24-
well Costar tissue culture plates at 0.5-50 Ag/ml for 60 min at room tempera-
ture, then rinsed well with adhesion medium. Cell-spreading assays were
performed withor without the addition of0.5 mg/ml synthetic peptide I exactly
as for fibronectin-coated substrates .
RESULTS
Inhibition of Fibronectin-mediated Cell Spreading
by Fibronectin
In a cell-spreading assay used routinely to quantitate fibro-
nectin biological activity (11, 16, 17), BHK cells spread nearly
completely on tissue culture substrates precoated with 3 tag/
mlhuman plasma fibronectin . As shown in Fig . 1 and quan-
titated in Fig. 2, this fibronectin-mediated spreading was
progressively inhibited by increased concentrations ofplasma
fibronectin added to the adhesion medium . Inhibition ap-
peared maximal at -10 mg/ml; various preparations dis-
played maximal inhibition at 6-12 mg/ml of soluble fibro-
nectin . Although spreading was severely inhibited, some cells
appeared to display abortive spreading, with increased phasedensity ofcytoplasm according to phase-contrast microscopy,
but with poor elaboration ofperipheral lamellae (Fig. 1).
Nine other proteins and glycoproteins that were tested at
10 mg/ml as controls for nonspecific effects ofprotein added
to the assaysystem did not affect fibronectin-mediatedspread-
ing of these cells(Table 1). Proteins without inhibitory effects
in this assay included fetuin and fibrinogen.
Inhibition of Fibronectin-mediated Cell Spreading
by a Cell-binding Fragment
A purified 75,000-dalton fragment of fibronectin which
displays nearly intact molar activity compared with native
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FIGURE 2 Inhibition of fibronectin-mediated spreading by in-
creased concentrations of added plasma fibronectin. Cells were
placed into dishes precoated with 3 jug/ml plasma fibronectin and
albumin and incubated in the presence of the indicated concentra-
tions of added plasma fibronectin. A total of 600 cells was scored
for spreading for each point; bars indicate standard deviation (n =
six fields).
TABLE I
fibronectin for mediating cell spreading (11) became inhibi-
tory when incubated in increased concentrations with BHK
cells (Figs. 1 and 3). Inhibition by this polypeptide fragment
was maximal at 0.5-1 .0 mg/ml, which is equivalent to a
concentration of -10' M peptide. Half-maximal inhibition
occurred at 2.4 x 10- 6 M 75,000-dalton fragment. Fig. 3 also
indicates that another fragment of fibronectin of 60,000 dal-
tons containing the collagen-binding domain had no effect
Concentrations of Peptides Required forHalf-maximal Inhibition of BHK Cell Spreading
COMPETING PROTEIN (mg/ml)
FIGURE 3 Inhibition of fibronectin-mediated spreading by a
75,000-dalton fragment of fibronectin containing the cell-binding
domain. The percentages of BHK cells that exhibited a spread
morphology on dishes coated with 3 ug/ml fibronectin in the
presence of the indicated concentrations of 75,000-dalton cell-
binding domain (75K) in solution or 60,000-dalton collagen-binding
domain (60K) in solution are indicated. The triangle on the ordinate
and the dashed line indicate the background level of cell spreading
on dishes not coated with fibronectin. Each point represents data
from 600 cells; bars indicate standard deviation for six random
microscope fields.
* Activities of peptides were determined for BHK cells on a substrate coated with 3 kg/ml plasma fibronectin in a 45-min cell-spreading assay performed as
described in Materials and Methods. Also tested were mixtures of free amino acids at the same molar concentrations as the amino acids present in 500 kg/ ml of either synthetic peptide I or synthetic peptide II; both mixtures were devoid of inhibitory activity.
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Peptide Amino acid sequence
Concentration
for half-maxi-
mal inhibition
Agfml-
Synthetic peptide I Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro 120
Synthetic peptide II Gly-Arg-Gly-Asp-Ser-Pro-Cys 32
Synthetic peptide III Cys-Gln-Asp-Ser-Glu-Thr- Arg-Thr-Phe-Tyr >500
Adrenocorticotropin >500
Aprotinin >500
Insulin chain A >500
Luteinizing hormone >500
Fibrinopeptide A Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg >500
Fibrinopeptide B pGlu-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg >500
Angiotensin I Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu >500
Bradykinin Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg >500
Melanocyte-stimulating hormone Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val >500
Neurotensin pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu >500
Oxytocin Cys-Tyr-lie-Gin-Asn-Cys-Pro-Leu-Gly >500
Tuftsin Thr-Lys-Pro-Arg >500
Arg-Gly-Pro-Phe-Pro-I le >500
Gly-Pro-Arg-Pro >500
Arg-Asp >500
Gly-Asp >500on fibronectin-mediated cell spreading. This fragment alone
had no intrinsic activity in mediating cell spreading (data not
shown).
Inhibition of Cell Spreading by Synthetic Peptides
A comparison of published (19-21) amino acid sequences
from a limited portion ofthe cell-binding region of fibronectin
is shown in Fig. 4. The sequences reveal a complete identity
ofamino acids between the three species, except for a con-
servative substitution of isoleucine for valine . We also focused
on this region because it contains the point of greatest local
hydrophilicity in the cell-binding domain, as determined for
averages of decapeptide units based on the values of Hopp
and Woods (reference 22 ; data not shown) . These properties
suggest that this region is evolutionarily conserved and partic-
ularly well exposed on the outer surface ofthe protein mole-
cule because of its paucity of hydrophobic residues . Two
synthetic peptides from this region were synthesized, one of
which contained an additional carboxyl-terminal cysteine res-
idue to permit coupling of the peptide to other proteins and
its labeling by alkylation.
As shown in Figs . 5 and 6, a synthetic decapeptide (peptide
I) from this region inhibited cell spreading. Inhibition was
FIGURE 4 Conserved cell-binding region of fibro-
nectin and two synthetic peptides. Partial amino acid
sequences from published data on the cell-binding
regions of human, bovine, and rat fibronectins are
-Cys
￿
listed (references 19-21), with the amino terminus at
the left . Synthetic peptide I is indicated by the upper bar, and it contains a relatively hydrophilic decapeptide sequence . Synthetic peptide
II is marked by the lower bar, and it contains a nonoverlapping glycine residue, five amino acids incommon with peptide I, and aCOOH-
terminal cysteine residue .
Human Ala Val Thr Gly Arg Gly Asp Ser Pro Ala Ser Ser Lys
Bovine Ala Val Thr Gly Arg Gly Asp Ser Pro Ala Ser Ser Lys
Rat
￿
Ala Val Thr Gly Arg Gly Asp Ser Pro Ala Ser Ser Lys
I
FIGURE 5
￿
Inhibition of fibronectin-mediated cell spreading by synthetic peptides . BHK cells attached to fibronectin-coated
plates with no additions (a and d), synthetic peptide I (SP 1) in solution at concentrations of 200 (6) or 500 Ag/ml (c), and synthetic
peptide II (SP 11) at concentrations of 200 (e) or 500 jig/ml (f) . Phase-contrast microscopy ; bar, 50,um .
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dose dependent, with half-maximal inhibition at 120 wg/ml.
A conserved decapeptide region from the collagen-binding
domain (peptide III) containing an identical amino acid se-
quence in comparisons ofbovine and chicken fibronectin (23,
24) was not inhibitory (Fig. 6) . A series of 15 other nonrelated
peptides shown in Table I also did not produce such inhibi-
tion .
Figs. 5 and 7 show that another synthetic peptide (peptide
II) containing five amino acids in common with the first
peptide was also an effective inhibitoroffibronectin-mediated
cell spreading. Half-maximal inhibition occurred at 32 wg/
ml. Alkylation of this peptide with iodoacetic acid to block
the free -SH group did not alter its inhibitory activity (Fig . 7).
The inhibition appeared to be competitive, since the inhib-
itory effect of synthetic peptide I was diminished in a dose-
dependent fashion as the amount of fibronectin preadsorbed
onto the substrate was increased by preincubation of the
dishes with increased amounts of fibronectin (Fig. 8). As
shown in Fig. 8, there was a 95% inhibition of spreading by
0.5 mg/ml synthetic decapeptide I at a low concentration of
fibronectin in the adsorption step, but <25% inhibition at the
highest concentration .
Fibronectin biological activity can also be quantitated by
Pro Ile Ser Ile
Pro Val Ser Ile
Pro Val Ser Ile0
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FIGURE 6
￿
Quantitation of the inhibition of cell spreading by syn-
thetic peptide I. BHK cells were incubated on tissue culture dishes
exposed to 3 leg/ml plasma fibronectin in the presence of the
indicated solution concentrations of the synthetic decapeptide I
(9), an equal volume of buffer (O), or 500 Ag/ml synthetic peptide
III (A) from the collagen-binding domain. Points indicate mean ±
SE of six random fields (600 cells each).
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FIGURE 7
￿
Quantitation of the inhibition of cell spreading by syn-
thetic peptide II. The percentage of cells with a spread morphology
on a substrate coated with 3 ug/ml plasma fibronectin is shown at
the indicated solution concentrations of synthetic peptide II (O) or
reduced and alkylated synthetic peptide II (9). Error bars facing to
the left indicate the standard errors for synthetic peptide II and
those facing to the right indicate standard errors for alkylated
synthetic peptide II; each point represents 600 cells.
Controls for Cytotoxicity
100
￿
200
SYNTHETIC PEPTIDE (,g/ml)
attachment assays by simply measuring the number of CHO
cells that attach or cannot attach to a type I collagen substrate.
A similar dose-dependent inhibition offibronectin-dependent
adhesion was observed (Fig. 9), indicating that the inhibitory
effect is not unique to an assay based on cell spreading.
None ofthe autogenous or synthetic inhibitors appeared to
be cytotoxic by phase-contrast microscopy (Fig. 5). Viabilities
as determined by trypan blue exclusion remained unaltered
(e.g., 98.4 ± 0.7% for control cells, 98.0 ± 1 .4% for cellswith
rounded morphology in the presence of 6 mg/ml plasma
fibronectin, and 99.2 ± 0.7% for rounded cellsin the presence
of 0.3 mg/ml synthetic decapeptide I).
Protein synthesis was also not substantially inhibited: the
incorporation of '4C-labeled amino acids into BHK cells
increased 33% in cells that had spread on fibronectin com-
pared with parallel cultures in dishes with no fibronectin
coating (uncoated = 28.2 ± 1 .8 x 104 cpm per 35-mm dish,
compared with 37.4 ± 6.6 x 104 cpm per dish on fibronectin-
coated dishes; values indicate mean ± SD, n = 3). Cells that
remained rounded in the presence of the highly inhibitory
synthetic peptide II at a concentration of 0.5 mg/ml incor-
porated amounts of radiolabeled amino acids similar to those
of the rounded control cells (24.2 ± 7 .5 x 104 cpm per dish
compared with 28.2 ± 1 .8 x 104 cpm per dish in controls).
Even a drastic inhibition of protein synthesis by treatment
with cyclohexamide does not inhibit fibronectin-mediated
spreading of BHK cells (reference 25; and data not shown).
Removal of the inhibitors resulted in a rapid re-initiation
of spreading to final percentages approaching control values,
further indicatingthe absence ofcytotoxicity (Fig. 10). In fact,
controls in which inhibitors remained present for a second
45-min assay period showed a modest recovery ofthe capacity
to spread even in the continued presence of synthetic deca-
peptide (Fig. 10; showing 5.7 ± 0.9% spread cells at 45 min
compared with 22.2 ± 5.8% after an additional 45 min).
There is particularly striking recovery of spreading in the
FIGURE 8
￿
Competitive nature of the inhibition by synthetic pep-
tide. The graph indicates the percent of total BHK cells with a
spread morphology coated with the indicated concentrations of
plasma fibronectin in the absence (O) or presence (0) of 0.5 mg/ml
synthetic peptide I in solution.
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FIGURE 9
￿
Inhibition of the adhesion of CHO cells to type I colla-
gen. Percent of control cell attachment to dishes coated with type
I collagen, preincubated with 3 ug/ml plasma fibronectin, then
incubated with the cells in the presence of the indicated concen-
trations of synthetic peptide l . Bars indicate standard error of
triplicate samples. Approximately 75% of the CHO cells initially
added to the dishes attached .in the controls (0 ug/ml peptide I).
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FIGURE 10
￿
Reversibility of the autoinhi-
bition by fibronectin (I) or by a synthetic
peptide (II). Percentage of BHK cells with
a flattened, spread morphology on a con-
trol fibronectin substrate after precoating
with 3 ug/ml plasma fibronectin (A) or the
same substrate plus 6 mg/ml soluble
plasma fibronectin in adhesion medium
(B), or after the same treatment with sol-
uble fibronectin for 45 min, followed by
three washes and a further incubation for
45 min in the absence of soluble fibronec-
tin (C). Spreading ofcontrol BHK cells with
3 wg/ml plasma fibronectin (D), fibronectin
plus 0.5 mg/ml synthetic peptide I (E), or
after washing and incubation for a second
45-min period in the absence of inhibitory
peptide (F). Control BHK cells were also
incubated on fibronectin for two consec-
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utive 45-min periods (G), plus the contin-
uous presence of 0.5 mg/ml synthetic peptide I (H), or after three washes of the control cultures (no peptide) after 45 min and a second
incubation for 45 min (1). Error bars indicate standard error, n = 6; 600 cells for each point.
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FIGURE 11 Inhibition by a synthetic peptide of cell spreading
mediated by a purified cell-binding fragment of fibronectin. The
percentage of BHK cells with a spread morphology is indicated for
control cells with no additions (A), compared with cells spreading
on dishes coated with 1 jug/ml 75,000-dalton cell-binding fragment
(75K) (B-D) in the presence of no additional peptide (B), 90,ug/ml
synthetic peptide I (C), or 270 /Ag/ml synthetic peptide I (D). Cells
were also examined using dishes coated with 2,ug/ml 75,000-dalton
cell-binding fragment (E and F) in the presence of no additional
peptide (E) or 270 lAg/ml synthetic peptide I (F). Note that the
inhibition by synthetic peptide is less when the cell-binding peptide
is present at twice the concentration.
presence of 10 mg/ml fibronectin (to 64.2 ± 3.1% after
incubation for an additional 45-min period).
It was possible that the inhibition occurred by interference
with a binding site on fibronectin unrelated to the "cell-
binding" site, e.g., with a heparin- or collagen-binding site.
However, Fig. 11 shows that synthetic peptide I caused a
similar dose-dependent inhibition of cell spreading that was
mediated by the 75,000-dalton cell-binding fragment; this
FN
1 5h
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FIGURE 12 Absence of
inhibition of concana-
valin A-mediated cell
spreading by synthetic
peptide I. The percent-
age of BHK cells with a
spread phenotype on
substrates precoated
with the indicated con-
ditions of concanavalin
A was determined as
described in Materials
and Methods in the ab-
sence (Q) or presence
CONCANAVALIN A (Ag/ml)
￿
(9) of 0.5 mg/ml syn-
thetic peptide I. The rectangular inset indicates the degree of
spreading of the BHK cells in this experiment when the substrate
was coated instead with plasma fibronectin at 3 ug/ml in the
absence (p) or in the presence (10 of the 0.5 mg/ml concentration
of synthetic peptide I. All values represent mean and standard error
(n = 6), based on counts of 600 cells per point.
fragment is known to lack heparin-, collagen-, and fibrin-
binding activities (11).
Effect of Concanavalin A-mediated Spreading
The lectin concanavalin A binds to cell surface glycocon-
jugates and mediates cell spreading (26, 27; Fig. 12). Such
lectin-mediated spreading was not inhibited by synthetic
decapeptide I in an experimentin which fibronectin-mediated
spreading was inhibited completely (Fig. 12). It is important
to note that no inhibition couldbe demonstrated even at low
concentrations of adsorbed concanavalin A, where inhibition
might be expected to be detected most easily.
DISCUSSION
Our major conclusions are (a) fibronectin-mediated adhesion
as measured by a standard cell-spreading assay can be inhib-
ited by fibronectin itself; (b) similar inhibition is produced by
a purified cell-binding fragment of 75,000 daltons and two
synthetic peptides from this region, but not by a series of
other proteins and peptides; (c) the inhibition appears to beC. Excess of Fragment
￿
FIGURE 13
￿
Theoretical interpretation of the auto-
inhibition of fibronectin function by fibronectin and
its fragments. (A) Cell-to-substrate adhesion me
diated by fibronectin adsorbed to a substrate. R
indicates a postulated saturable receptor for fibro-
nectin. The receptor binds to the cell-binding (rec-
ognition) site on fibronectin (curved appendage on
the closed square). (B) Inhibition of fibronectin-me-
diated adhesion by incubation ofcellswith an excess
of soluble fibronectin. A sufficiently high concentra-
tion of fibronectin would occupy most receptors,
resulting in inability of these receptors to bind to substrate-adsorbed fibronectin. (C) Inhibition of fibronectin-mediated adhesion by
fragments of fibronectin. Fragments that can still be recognized by the postulated receptor could also block the receptors. This model
could be generalized to all cell adhesion proteins that function by binding to a specific, saturable receptor.
A. Normal Adhesion B. Excess Adhesion Protein
competitive, and can be overcome at leastpartially by higher
concentrations of adsorbed fibronectin or by substantially
longer incubation times; and (d) similar inhibition is found
in an assay measuring fibronectin-mediated cell attachment
to type I collagen, but not in an assay of fibronectin-inde-
pendent cell spreading mediated by a lectin.
The simplest interpretation of our results is summarized in
Fig. 13. Fibronectin is known to be highly effective as a cell-
to-substrate adhesion molecule after it has been adsorbed to
a substrate (3-9, 28, 29; Fig. 13 A). However, our data indicate
that the same molecule can become inhibitory if it is present
in sufficient quantities in solution (Fig. 13B); certain frag-
ments of this adhesive molecule can also be inhibitory (Fig.
13 C). The most likely target for this specific inhibition would
be a saturable, receptor-like moiety.
The concentrations of soluble fibronectin required for half-
maximal inhibition may provide an estimate of the apparent
affinity of soluble fibronectin for its "receptor" on the cell
surface. The most effective inhibitor was the cell-binding
fragment, which inhibited spreading maximally at a concen-
tration of -10` M. If such inhibition requires saturation by
a 10-fold excess of protein, the affinity (dissociation constant)
would be 10-6 M. Recently, direct binding studies with triti-
ated plasma fibronectin yielded an apparent dissociation con-
stant of 0.8 x 10'6 M (S. K. Akiyama and K. M. Yamada,
submitted for publication).
The decrease in effectiveness of this autogenous inhibition
when more fibronectin was adsorbed onto the substrate or
when the incubation time was prolonged may be explained
by the multivalency, and therefore higher expected effective
affinity, ofmolecules adsorbed onto a substrate. In fact, it had
been suggested previously that fibronectin requires aggrega-
tion or adsorption onto a surface such as a culture dish or a
bead in sufficiently high concentrations in order to interact
with a low-affinity receptor (2, 30). Substrate-attached, mul-
tivalent ligands would be expected to compete more effec-
tively for cellular receptors than monovalent or divalent li-
gands such as intact fibronectin, its cell-binding fragment,
and peptides. Increased quantities ofsubstrate-adsorbed fibro-
nectin or longer incubation times would be expected to favor
the formation of adhesive bonds with fibronectin on the
substrate, thus permitting cell spreading even in the presence
of soluble autogenous inhibitors.
A previous study from our laboratory reported the inhibi-
tion ofcell attachment to collagen afterpreincubation of cells
with a cell-binding fragment of cellular fibronectin; the final
concentrations of fragment were quite low (<14 pg/ml). The
inability of our and other laboratories to repeat this observa-
tion with equal concentrations of soluble plasma fibronectin
or Recognition Site
or its cell-binding fragment supports the hypothesis that the
cellular form offibronectin can bind to cellswith high appar-
ent affinity because it is aggregated; a requirement for fibro-
nectin to be aggregated or adsorbed to a substrate to bind
effectively to its receptor has been suggested (2, 4, 28-30).
Our results, however, suggest the existence of direct interac-
tions ofsoluble molecules with the putative fibronectin recep-
tor, since soluble plasma fibronectin, its 75,000-dalton frag-
ment, and highly soluble, hydrophilic synthetic peptides can
all function effectively as inhibitors.
The efficacy of synthetic peptides as inhibitors suggests that
they may be useful probes of fibronectin-related adhesion in
vivo. The synthetic decapeptide was specific in that it did not
inhibit another cell-spreading event, i.e., lectin-mediated
spreading, but it is important to note that the specificity of
such peptides for fibronectin as compared with other attach-
ment factors such as laminin remains to be determined.
Inhibition of normal rat kidney cell attachment by related
synthetic peptides has been reportedrecentlyby Pierschbacher
and Ruoslahti in work accepted for publication after the
completion of our study (31). They discovered that the se-
quence Arg-Gly-Asp-Serwas the minimal sequence necessary
to mediate cell attachment, and they were able to estimate
the affinity constants ofpeptides containing this sequence for
binding to the cell surface as 3-6 x 10-° M. The inhibitory
activities of synthetic peptides in their assay were less than for
the synthetic peptides in our study, perhaps as a result of
differences in assay conditions or cell types.
Ourexperiments indicate that adhesion proteins can display
either positive or negative activities depending on their con-
centrations and locations, i.e., in solution or bound to a
substrate. The concentration of fibronectin in human plasma
is 0.3 mg/ml; it is interesting that some inhibition wasdetected
even at 1 .5 mg/ml (Fig. 2). It is possible that similar antago-
nistic relationships might occur in vivo, and that weakening
ofadhesive interactions might result from events that increase
the local concentrations of soluble adhesive proteins, e.g., in
certain disease states or possibly even at localized regions on
the cell surface near the sitesof secretion of such molecules.
A portion of this study was presented at the Joint Meeting of the
British Societies for Cell Biology and Developmental Biology, Sep-
tember, 1983.
Receivedforpublication 5 March1984, andin revisedform 29 March
1984.
Note Added in Proof Plasma fibronectin and a mixture of its
proteolytic fragments were recently found to produce a partial, tran-
YAMADA AND KENNEDY
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35sient inhibition of hepatocyte attachment to fibronectin (Johansson,
S., and M. H66k, 1984, J. Cell BioL, 98:810-817).
REFERENCES
I. Frazier, W. A.. and L. Glaser. 1979. Surface components and cell recognition . Anna.
Rev. Bioehem.48:491-523.
2. Grinnell, F. 1983. Cell attachment and spreading factors. In Growth and Maturation
Factors. G. Guroff, editor. John Wiley and Sons, New York. 267-292.
3. Mosesson, M. W., and D. L. Amrani. 1980. The structure and biologic activities of
plasma fibronectin . Blond. 56:145-158.
4. Pearlstein, E., L. I. Gold, and A. Garcia-Pardo. 1980. Fibronectin : a review of its
structure and biological activity. Mol. Cell. Biochem. 29:103-128.
5. Ruoslahti, E., E. Engvall, and E. G. Hayman. 1981. Fibronectin: current concepts ofits
structure and functions . Collagen RelatedResearch. 1:95-128.
6. Hynes. R. O., and K. M. Yamada. 1982. Fibronectins: multifunctional modular glyco-
proteins. J. Cell Biol. 95:369-377.
7. Aplin.J. D., and R. C. Hughes. 1982. Complex carbohydrates ofthe extracellularmatrix.
Structure. interactionsand biological roles. Biochim. Biophys. Acta. 694:375-418.
8. Yamada, K. M. 1983. Cell surface interactions with extracellular materials. Annu. Rev.
Biochem.52:761-799.
9. Mosher, D. F., editor. 1984. Fibronectin . Academic Press, Inc., New York. In press.
10. Pierschbacher, M. D., E. G., Hayman, and E. Ruoslahti . 1981. Location of the cell-
attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of
the molecule. Cell. 26:259-267.
11. Hayashi, M., and K. M. Yamada. 1983. Domain structure ofthe carboxyl-terminal half
ofhuman plasma fibronectin . J. Biol. Chem. 258:3332-3340.
12. Pierschbacher. M. D., E. G. Hayman, and E. Ruoslahti . 1983. Synthetic peptide with
cell attachment activity offibronectin. Proc. Nail. Acad. Sci. USA. 80:1224-1227.
13. Engvall, E.,and E. Ruoslahti . 1977. Binding ofsoluble formoffibroblast surface protein.
fibronectin, to collagen. Int. J. Cancer. 20:1-5.
14. Yamada, K. M. 1983. Isolation offibronectin from plasma and cells. In Immunochem-
istry ofthe Extracellular Matrix, Vol. 1. H. Furthmayr,editor. CRC Press, Boca Raton,
Florida. I I 1-123.
15. Miekka, S. 1., K. C. Ingham, and D. Menache. 1982. Rapid methods for isolation of
human plasma fibronectin . Thromh. Res. 27:1-14.
36
￿
THE JOURNAL OF CELL BIOLOGY - VOLUME 99, 1984
16. Hahn, L. H. E., and K. M. Yamada. 1979. Isolation and biological characterization of
active fragments ofthe adhesive glycoprotein fibronectin. Cell. 18:1043-1051 .
17. Grinnell, F.. D. G. Hays, and D. Minter. 1977. Cell adhesion and spreading factor:
partial purification and properties. Exp. Cell Res. 110:175-190.
18. Grinnell, F., and M. K. Feld. 1981 . Adsorption characteristics ofplasma fibronectin in
relationship to biological activity. J. Biomed. Mater. Res. 15:363-381.
19. Pierschbacher, M. D., E. Ruoslahti, J. Sundelin, P. Lind, and P. A. Peterson. 1982. The
cell attachment domain of fibronectin . Determination ofthe primary structure. J. Biol.
Chem. 257:9593-9597.
20. Petersen, T. E., H. C. Thogersen, K. Skorstengaard, K. Vibe-Petersen, P. Sahl, L.
Sottrup-Jensen, and S. Magnusson. 1983. Partial primary structure ofbovine plasma
fibronectin : three types of internal homology. Proc. Nail. Acad. Sci. USA. 80:137-141 .
21. Schwarzbauer, J. E., J. W. Tamkun, 1. R. Lemischka, and R. O. Hynes. 1983. Three
different fibronectin mRNAs arise by alternative splicingwithin the coding region. Cell.
35:421-431.
22. Hopp, T. P., and K. R. Woods. 1981. Prediction ofprotein antigenic determinants from
amino acid sequences. Proc. Nall. Acad. Set. USA. 78:3824-3828.
23. Hirano, H.. Y. Yamada, M. Sullivan, B. de Crombrugghe, I. Pastan, and K. M. Yamada.
1983. Isolation ofgenomic DNA clones spanningthe entirefibronectin gene. Proc. Nail.
Acad. Sci. USA. 80:46-50.
24. Petersen, T. E., K. Skorstengaard, P. Sahl, K. Vibe-Petersen, and H. C. Thogersen.
Primary structure offibronectin. In Fibronectin . D. F. Mosher, editor. Academic Press,
Inc., New York. In press.
25. Tarone, G., G. Galetto, M. Prat, and P. M. Comoglio. 1982. Cell surface molecules and
fibronectin-mediated cell adhesion: effect ofproteolytic digestion of membrane proteins.
J. Cell Biol. 94:179-186.
26. Grinnell, F., and D. G. Hays. 1978. Induction ofcell spreadingby substratum-adsorbed
ligandsdirected against the cell surface. Exp. Cell Res. 116:275-284.
27. Aplin, 1. D., and R. C. Hughes. 1981 . Cell adhesion on model substrata: threshold
effectsand receptor modulation. J. Cell Sci. 50:89-103.
28. Klebe, R. J. 1974. Isolation of a collagen-dependent cell attachment factor. Nature
(Lond.).250:248-251.
29. Kleinman, H. K., R. J. Klebe, and G. R. Martin. 1981 . Role ofcollagenous matrices in
the adhesion and growth of cells. J. Cell Biol. 88:473-485.
30. McAbee, D. D., and F. Grinnell. 1983. Fibronectin-mediatedbinding and phagocytosis
ofpolystyrene latex beads by baby hamster kidney cells. J. CellBiol. 97:1515-1523.
31. Pierschbacher, M. D., and E. Ruoslahti. 1984. The cell attachment activityoffibronectin
can beduplicated by small synthetic fragmentsofthe molecule. Nature(Lond.). In press.